Dr. Reddy’s Laboratories (NYSE:RDY) Upgraded at HSBC
HSBC upgraded shares of Dr. Reddy’s Laboratories (NYSE:RDY – Free Report) from a hold rating to a buy rating in a research note published on Thursday morning, Marketbeat.com reports. The firm currently has $16.90 price objective on the stock, up from their prior price objective of $14.44. Separately, Wall Street Zen raised shares of Dr. […]
HSBC upgraded shares of Dr. Reddy’s Laboratories (NYSE:RDY – Free Report) from a hold rating to a buy rating in a research note published on Thursday morning, Marketbeat.com reports. The firm currently has $16.90 price objective on the stock, up from their prior price objective of $14.44. Separately, Wall Street Zen raised shares of Dr. […]
